Clinical Trial

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Study acronym: EpiDOSE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this randomized controlled trial is to evaluate the effectiveness of a low cumulative dose of epinephrine compared to a standard cumulative dose of epinephrine during resuscitation from ventricular fibrillation (VF) or ventricular tachycardia (VT) in adult out-of-hospital cardiac arrest (OHCA) patients.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-01-30; most recent amendment 2025-12-09.
Status change: Not Yet Recruiting → Recruiting 2023-06-02
Trial Details
NCT Number NCT03826524
Lead Sponsor Unity Health Toronto
Collaborators: Canadian Institutes of Health Research (CIHR), Pfizer
Conditions Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation, Ventricular Tachycardia-Pulseless
Enrollment 3,790 participants
Start Date 2023-05-24
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-11